It is unknown what percentage of CVID patients presents with clinical symptoms of interstitial lung diseases preceding the diagnosis of immunodeficiency. Most studies on ILD in CVID patients focused on possible risk factors for developing non-infectious pulmonary complications and how ILD affects the clinical course in these patients.